Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.

Emery CM, Monaco KA, Wang P, Balak M, Freeman A, Meltzer J, Delach SM, Rakiec D, Ruddy DA, Korn JM, Haling J, Acker MG, Caponigro G.

Mol Cancer Res. 2017 Oct;15(10):1431-1444. doi: 10.1158/1541-7786.MCR-17-0211. Epub 2017 Jun 27.

2.

Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death.

Emert-Sedlak L, Shangary S, Rabinovitz A, Miranda MB, Delach SM, Johnson DE.

Mol Cancer Ther. 2005 May;4(5):733-42.

4.

Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein.

Antoku K, Maser RS, Scully WJ Jr, Delach SM, Johnson DE.

Biochem Biophys Res Commun. 2001 Sep 7;286(5):1003-10.

PMID:
11527400
5.

Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis.

Fattman CL, Delach SM, Dou QP, Johnson DE.

Oncogene. 2001 May 24;20(23):2918-26.

6.

Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis.

Johnson DE, Gastman BR, Wieckowski E, Wang GQ, Amoscato A, Delach SM, Rabinowich H.

Cancer Res. 2000 Apr 1;60(7):1818-23.

Supplemental Content

Loading ...
Support Center